MO presented my case (details in profile) to the clinical panel (medical oncologists, urologists, radiation oncologists) in order to recommend the next course of action. He expected "debulking" recommendation would prevail. Surprisingly, the surgery option didn't receive much support. All of them agreed that at my stage and considering young age the possible side-effects and quality of life consequences outweigh unclear benefits RP may bring. The similar notion was around radiation therapy although they agreed that I may benefit more and should consider it. Again, this suggestion was not a strong one, so I have to meet with RO, discuss options and decide for myself.
Another option is include Zytiga early and see how it goes. Again, no RCT showing benefit of close sequencing docetaxel and Zytiga yet.
As of now, I'm thinking to get a 2nd opinion on other possible options but most likely will receive similar with a slight nudge depending on what type of doctor and school I will talk to.
I thought of my options (a risky one) is to continue on Lupron for 3-6 more months and see how it goes. If everything is good, then try to stop ADT and wait until PSA rases over 2.0. Then perform PSMA C11 or other sensitive PET scan to find where the cancer is hiding. And only then go after it with precision therapy, be it surgery or radiation. If ADT works long enough, I can extend it and wait until new treatments pop up on the horizon. In any case I'd like to extend hormone-sensitive phase as long as possible.